19 May 2013
Keywords: Eisai, Inovelon, Epilepsy, Lennox-Gastaut syndrome, Swissmedic, Switzerland
Article | 12 July 2012
Japanese drug major Eisai’s (TYO: 45230) European subsidiary says that the regulatory agency Swissmedic has approval its Inovelon ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 July 2012
17 May 2013
© 2013 thepharmaletter.com